Purpose: To describe a highly recognizable and reproducible retinal phenotype associated with a specific BEST1 mutation-p.Ala243Val.
M utations in the BEST1 gene are a common cause of inherited macular disease. 1 In the majority of cases, heterozygous missense variants in the first half of the gene result in a single vitelliform lesion centered on the macula, the classic phenotype associated with Best disease (BD, OMIM 153700). 2, 3 Most have a family history consistent with dominant transmission, although nonpenetrant carriers rarely occur. 4 Less commonly homozygous or compound heterozygous mutations in BEST1 result in recessive disease. 4 This is usually associated with multifocal subretinal deposit, intraretinal and subretinal fluid accumulation even in the absence of choroidal neovascular membrane, short axial length, and narrow iridocorneal angles. 5 In addition, much rarer phenotypes also have been described (microcornea, rod-cone dystrophy, cataract and posterior staphyloma, autosomal dominant vitreo-retino-choroidopathy [both OMIM 193220] , and retinitis pigmentosa [OMIM 613194]). 6, 7 In addition to causing BD, a maculopathy usually evident in childhood, mutation of BEST1 can also produce a similar appearance later in life, often after the fourth decade. Adult-onset vitelliform macular dystrophy (OMIM 608161) is genetically heterogeneous with pathogenic variants in PRPH2, IMPG1, and IMPG2 as well as BEST1 associated with this phenotype. 8 Perhaps, the least well-recognized presentation of BEST1-related retinopathy is a form that mimics the reticular type of pattern dystrophy (PD). [9] [10] [11] Here, we present a detailed investigation of a subset of patients presenting with a PD, all found to result from the p.Ala243Val BEST1 mutation. Table 1) presented to the eye clinic at Moorfields Eye Hospital, London and was diagnosed with a macular dystrophy after clinical and electrophysiological examinations. Molecular genetic testing identified p.Ala243Val BEST1 as the causative variant. As the presentation was not typical for BD, we chose to further investigate the phenotype associated with this specific mutation, interrogating an in-house database to identify all patients harboring this variant. The clinical findings were then compared with those seen with the most prevalent BEST1 mutation, p. Arg218Cys, chosen to serve as an example of "classic" BD. Finally, the phenotype associated with all other BEST1 variants in our database were reviewed to determine how unique this phenotype really is.
Methods

Patient 4 (
Clinical details and patient demographics were reviewed using the patients' hospital notes and electronic patient records (OpenEyes, London, United Kingdom). Fundus images included optical coherence tomography (OCT) with accompanying near-infrared reflectance imaging and fundus autofluorescence (FAF), both acquired using the Spectralis HRA and OCT system (Heidelberg Engineering, Heidelberg, Germany). Electrophysiological testing was performed incorporating the International Society of Clinical Electrophysiology of Vision standards and included full-field electroretinogram, pattern electroretinogram, and electrooculogram (EOG). 12, 13 Molecular testing was performed either by Sanger sequencing (National Genetics Reference Laboratory, Manchester, United Kingdom) or by targeted Next Generation Sequencing of genes known to cause macular dystrophy (Macular panel; Casey Eye Institute, Portland, OR). All patients had previously provided informed consent as part of a genetics research project approved by the local research ethics committee, and all investigations were conducted in accordance with the principles of the Declaration of Helsinki. The data were analyzed using nonparametric statistical methods (Mann-Whitney U test) and presented as median plus interquartile range (IQR). Significance was reported testing at the 5% level.
Results
Eight individuals (6 families) were identified with the p.Ala243Val BEST1 mutation and 7 patients with the pathologic variant p.Arg218Cys (Table 1 Fundus examination identified classic changes associated with BD in all patients with mutation of codon 218-representative of the various stages of disease ( Figure 1A ). This was confirmed by retinal imaging (spectral-domain OCT and FAF, Figure 1 , B and C). Patients with the p.Ala243Val mutation, however, did not always share this typical appearance. A single macular lesion was usually identifiable on fundoscopy, especially early in the disease course (Patient 1a; Figure 2A ). Later, peripheral spokes may have developed, giving the impression of a PD ( Figure 2B ).
The spectral-domain OCT scans confirmed the presence of subretinal fluid, a hallmark of BEST1-related retinopathy. In addition, small amounts of subretinal deposit were seen to collect preferentially in the periphery of the elevated neurosensory retina, either in a continuous ring of peripheral deposit ( Figure 3A ) or as radiating spokes ( Figure 3B ). This material was highly reflective when viewed with near-infrared reflectance imaging and most easily visible with this modality ( Figure 4 , A and B). In some cases, these changes extended into the peripheral macula ( Figure  4C ). Areas of outer retinal thickening, particularly in the superior retina involving the interdigitating zone, were also noted. A similar pattern of change was identifiable on FAF, although subjectively this seemed as a less sensitive method of detection ( Figure 5 , A and B). Subretinal deposit was associated with hyperautofluorescence, and in some cases a deposit: fluid interface was seen. Again with this modality, the main lesion in most cases did not conform to an approximately circular shape and often had radial spoke-like extensions. Similar OCT or FAF changes were not observed with the allele p.Arg218Cys.
Electrophysiological testing was available for review in seven of eight cases associated with BEST1 p.Ala243Val. The full field electroretinogram (ffERG) was normal in all cases, whereas the EOG and pattern electroretinogram were abnormal in all but one patient who had a normal EOG (Patient 5). The median Arden ratio was 130% (IQR = 24). The absence of a light rise in 2 cases (Patients 3 and 4) directed genetic screening toward BEST1. In contrast, the p.Arg218Cys mutation was always associated with a reduced Arden ratio in the 4 of 7 cases tested, with a median amplitude of 117.5% (IQR = 10). These data suggest that this specific mutation of codon 243 has less impact on the amplitude of the EOG light rise than the p.Arg218Cys variant (Mann-Whitney U test; P , 0.05).
In an attempt to discover whether this specific phenotype is seen in the context of other BEST1 genotypes, we then reviewed the retinal images of other patients, identified from an in-house database, known to have molecularly proven BD. The retinal appearance resulting from p.Ala243Val BEST1 was not reproduced by more than 20 further genotypes.
Discussion
In this work, we describe a highly recognizable and reproducible retinal phenotype associated with a specific BEST1 mutation-p.Ala243Val. The unique anatomical changes are best identified with near-infrared reflectance imaging, in addition to spectral-domain OCT and FAF. Functional analysis suggests that this variant is thought to be milder than other causes of BD, as patients develop symptoms at a later age and tend to 
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have better preservation of EOG amplitudes. These in vivo data will be invaluable both clinically, aiding the diagnosis of new cases, and scientifically, when attempting to better understand this protein's function.
So far, more than 200 mutations in BEST1 have been described, most of which are heterozygous and associated with a vitelliform macular dystrophy (http:// www-huge.uni-regensburg.de/BEST1_database). Best disease in its classic form is a childhood-onset condition characterized by the accumulation of subretinal deposit centered on the fovea. 4 Causative genetic variants almost exclusively occur in the highly conserved amino terminal domain of BEST1 (amino acids 1-390), and it is thought that missense mutations causing BD act by exerting a dominantnegative effect, altering calcium-sensitive chloride conductance through this channel. 14 BEST1 haploinsufficiency, as occurs in carriers of recessive BEST1 disease, is not associated with any detectable retinopathy. The phenotype arising from the p.Ala243Val mutation is milder than classic BD, with a later age of visual loss and absence of a large volume of central deposit.
The substitution p.Ala243Val has been previously identified as a cause of BD, adult-onset vitelliform macular dystrophy, and in one report PD. Krämer et al 15 describe 3 pedigrees with BD and 5 with adult-onset vitelliform macular dystrophy arising from mutation of codon 243. Unusually, the patients with BD were older than expected (most were symptomatic after the age of 30 years) and the sole pediatric patient aged 15 years showed only the earliest signs of disease (described by the authors as previtelliform stage). Although clinical images are not available, the description is that of a milder disease than is usual for BD. Best disease has also been reported once before with the same genotype, by Chung et al 16 in 2001. This patient, aged 23 years, was seen with a unilateral gliotic macular scar presumed to result from previous choroidal neovascularization. There was no comment on the fellow eye. The same mutation was reported by Querques et al 17 in 2009, where they describe five members of one family. No fundus images are available for review. The youngest mutation carriers (aged 13 and 17 years) had not yet developed a visible phenotype, again perhaps suggesting a disorder with a later onset. Finally, and in the only case where fundus images were published, Boon et al 18 describe a patient with a PD-type maculopathy because of the p. Ala243Val mutation. In this case, and most of the cases herein, the Arden ratio was found to be larger than that usually associated with BD. The clinical evidence presented therefore supports a role for this variant having a milder effect than most heterozygous mutations in BEST1.
The BEST1 gene encodes a channel protein that selectively transports anions and localizes to the basolateral retinal pigment epithelium (RPE) cell membrane. [19] [20] [21] [22] Recently, however, an alternative location has been suggested. Singh et al 23 generated mutant RPE cells using induced pluripotent stem cells derived from fibroblasts of patients with BD. They propose that the channel is sited in the RPE cytosol, near to but not actually in the basolateral membrane, probably residing in the endoplasmic reticulum. Although its preference is for chloride ions, the channel may additionally transport other monovalent anions (bromine, iodine, thiocyanate, bicarbonate, and nitrate) and even glutamate and g-aminobutyric acid. 24 In the endoplasmic reticulum, it is thought to have a role in calcium homeostasis. Given its role in ion flux, it is not surprising that the functional effects of gene mutation have been studied by patch clamping recombinant BEST1 channels in vitro. Yu et al 25 used this technique to model the effects of p. Ala243Val mutation in HEK293 cells and identified currents approximately 10% as large as those measured through wild-type channels. 25 They were also able to show that p.Ala243Val BEST1 is expressed on the cell surface at approximately the same level as p.Ala243Val BEST1 FUNDUS PHENOTYPE KHAN ET AL wild-type BEST1, suggesting that this missense mutation reduces ion conductance through the channel rather than mislocalizing the channel. Normal localization associated with this particular mutation has also been recognized by others. 26, 27 These data are also in keeping with a hypothesis where the effects of mutation are to alter normal function. A more dramatic change in function, perhaps even a reversal of polarity, may be associated with mutation of key pore-forming residues. 28 Although it is easy to understand what constitutes a milder form of disease, one with a later onset and less pronounced maculopathy, it is not intuitive how this is brought about at a molecular level. A major difference between the PD and vitelliform phenotypes is the reduced quantity of subretinal deposit in the former, and an altered distribution. The accumulating material in classic BD is usually highly autofluorescent and derives from undigested photoreceptor outer segments loaded with bisretinoid product that are thought to accumulate because of impaired phagocytosis. A similar phenotype occurs with mutation of PRPH2, where mutated photoreceptor outer segments are either shed in greater numbers or are more resistant to RPE phagocytosis. 8 Finally, mutation of IMPG1 and IMPG2 can also generate a vitelliform maculopathy, and again, it is suggested that impaired clearance of outer segments is the cause. 29 Here, the p.Ala243Val mutation is associated with significant amounts of subretinal fluid, even in the earliest stages of disease. It may well be that detachment of the neurosensory retina is the primary event, and photoreceptor outer segments accumulate as a consequence, in a manner not dissimilar to that observed with another retinal disease -central serous chorioretinopathy. This mutation may therefore impair a specific aspect of RPE function, uniquely altering ion flux and the associated osmotic movement of water, while a different physiologic process may be relatively spared-phagocytosis of photoreceptor outer segments. Although the genetic mechanisms responsible are widespread, present in all RPE cells, the clinical phenotype is likely to be influenced by both variations in regional metabolic activity (macular vs. peripheral retina) and the differences between populations of RPE cells even within the macula. As RPE cells are understood to migrate centrifugally during ocular organogenesis, radial patterns of central RPE disease have long been identified (e.g., dominant drusen in association with mutation of EFEMP1). Here, subretinal deposit may therefore accumulate in a pattern determined primarily by clonal origin rather than by gravity alone.
In summary, this study describes a new retinal phenotype associated with the p.Ala243Val BEST1 genotype. Our study demonstrates the association of a reticular PD-like appearance with mutation in BEST1, in addition to the long recognized association with PRPH2, and so should be considered in the differential diagnosis. This specific mutation is also associated with a later age of disease onset and with greater EOG amplitudes than are usually associated with BD. These clinical characteristics may provide mechanistic insight, suggesting that the p.Ala243Val mutation acts primarily to impair ion transport and the associated movement of fluid, with minimal disruption to RPE phagocytosis, resulting in a later-onset maculopathy. Family surveys may be necessary to identify similarly affected individuals. . Each modality seems to identify a slightly different feature of disease-near-infrared reflectance imaging seems to be particularly sensitive to subtle separation of the neurosensory retinal from the RPE, with increased reflectivity evident in regions with no or minimal change in autofluorescence (white arrows). Fundus autofluorescence seems to be a more sensitive technique for detecting larger quantities of subretinal deposit (red arrows).
